Results 11 to 20 of about 184,022 (213)

Public Perspective on Hyperlipidemia Drugs and Sentiments About Hyperlipidemia on Twitter

open access: yesBorneo Journal of Pharmacy, 2023
Hyperlipidemia is a non-communicable disease (NCD) caused by several factors, such as a person's socioeconomic status, culture, customs, habits, and lifestyle.
Murojil Hasan   +2 more
doaj   +3 more sources

Pediatric hyperlipidemia

open access: yesIndian Heart Journal
The leading cause of mortality worldwide is atherosclerotic cardiovascular disease. Atherosclerotic plaques are well known to originate early in the childhood.
Ankit Garg, S. Radhakrishnan
doaj   +3 more sources

Hyperlipidemia in Equine, Canine and Feline

open access: yes, 2022
Hyperlipidemia is defined by the presence of elevated lipid concentrations in blood and are typically associated with periods of negative energy balance and physiologic stress.
Hyperlipidemia in Equine, Canine and Feline
core   +1 more source

The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism

open access: yesBMC Pharmacology and Toxicology, 2021
Background Vitamin D deficiency is prevalent in patients with non-alcoholic fatty liver disease (NAFLD), but there are debates on the usefulness of vitamin D treatment.
Hamid Yaghooti   +4 more
doaj   +1 more source

Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions

open access: yesJournal of Lipid Research, 1997
In order to assess the relationship between plasma accumulation of triglyceride-rich lipoproteins (TRL) and lipoprotein levels of apoC-III and apoE, we have measured apoC-III and apoE in lipoproteins separated according to size (by automated gel ...
A Fredenrich   +5 more
doaj   +1 more source

Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome [PDF]

open access: yes, 1987
The mechanism leading to hyperlipidemia in the nephrotic syndrome is not fully understood but may be related in part to loss of high density lipoproteins in the urine of patients with nephrosis.
Caselmann, Wolfgang H.   +3 more
core   +1 more source

Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE.

open access: yesJournal of Lipid Research, 1997
We have used two-dimensional gel electrophoresis to separate and characterize human plasma apolipoprotein (apo) E-containing lipoproteins in the high density lipoprotein (HDL) size range.
L Krimbou   +3 more
doaj   +1 more source

Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

open access: yesJournal of Lipid Research, 2000
Apolipoprotein (apo) C-III and apoE play a central role in controlling the plasma metabolism of triglyceride-rich lipoproteins (TRL). We have investigated the plasma kinetics of total, very low density lipoprotein (VLDL) and high density lipoprotein (HDL)
Rami Batal   +7 more
doaj   +1 more source

Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans

open access: yesJournal of Lipid Research, 2003
Numerous factors are known to affect the plasma metabolism of HDL, including lipoprotein receptors, lipid transfer protein, lipolytic enzymes and HDL apolipoproteins.
Jeffrey S. Cohn   +7 more
doaj   +1 more source

Analytical isoelectric focusing with immobilized pH gradients of human apolipoprotein E from very low density lipoproteins and total plasma.

open access: yesJournal of Lipid Research, 1990
A method for analytical isoelectric focusing (IEF) of apolipoprotein E (apoE) in immobilized pH gradients (IPG) and immunodetection of the separated isoforms has been developed for use with either very low density lipoproteins (VLDL) or whole plasma ...
F Mailly, J Davignon, AC Nestruck
doaj   +1 more source

Home - About - Disclaimer - Privacy